Literature DB >> 19561100

Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity.

Tanja Schreiber1, Stefan Ehlers, Lisa Heitmann, Alexandra Rausch, Jörg Mages, Peter J Murray, Roland Lang, Christoph Hölscher.   

Abstract

Elevated IL-10 has been implicated in reactivation tuberculosis (TB). Since macrophages rather than T cells were reported to be the major source of IL-10 in TB, we analyzed the consequences of a macrophage-specific overexpression of IL-10 in transgenic mice (macIL-10-transgenic) after aerosol infection with Mycobacterium tuberculosis (Mtb). MacIL-10 transgenic mice were more susceptible to chronic Mtb infection than nontransgenic littermates, exhibiting higher bacterial loads in the lung after 12 wk of infection and dying significantly earlier than controls. The differentiation, recruitment, and activation of Th1 cells as well as the induction of IFN-gamma-dependent effector genes against Mtb were not affected by macrophage-derived IL-10. However, microarray analysis of pulmonary gene expression revealed patterns characteristic of alternative macrophage activation that were overrepresented in Mtb-infected macIL-10 transgenic mice. Importantly, arginase-1 gene expression and activity were strikingly enhanced in transgenic mice accompanied by a reduced production of reactive nitrogen intermediates. Moreover, IL-10-dependent arginase-1 induction diminished antimycobacterial effector mechanisms in macrophages. Taken together, macrophage-derived IL-10 triggers aspects of alternative macrophage activation and promotes Mtb recrudescence independent of overt effects on anti-TB T cell immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561100      PMCID: PMC2735238          DOI: 10.4049/jimmunol.0803567

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

Authors:  R T Gazzinelli; I P Oswald; S L James; A Sher
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

2.  Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production.

Authors:  S E Macatonia; T M Doherty; S C Knight; A O'Garra
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

3.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

4.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10.

Authors:  I E Flesch; J H Hess; I P Oswald; S H Kaufmann
Journal:  Int Immunol       Date:  1994-05       Impact factor: 4.823

7.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.

Authors:  J Chan; K Tanaka; D Carroll; J Flynn; B R Bloom
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

9.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  77 in total

1.  Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells.

Authors:  Maria R Fernando; Mark A Giembycz; Derek M McKay
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

Review 2.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

3.  BAC talk about cell type-specific regulation of human IL-10.

Authors:  David Sacks
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

4.  Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis.

Authors:  Claire Lastrucci; Alan Bénard; Luciana Balboa; Karine Pingris; Shanti Souriant; Renaud Poincloux; Talal Al Saati; Voahangy Rasolofo; Pablo González-Montaner; Sandra Inwentarz; Eduardo Jose Moraña; Ivanela Kondova; Frank A W Verreck; Maria del Carmen Sasiain; Olivier Neyrolles; Isabelle Maridonneau-Parini; Geanncarlo Lugo-Villarino; Céline Cougoule
Journal:  Cell Res       Date:  2015-10-20       Impact factor: 25.617

Review 5.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 6.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

7.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors:  Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

8.  Chitin particles induce size-dependent but carbohydrate-independent innate eosinophilia.

Authors:  Mari Kogiso; Akihito Nishiyama; Tsutomu Shinohara; Masataka Nakamura; Emiko Mizoguchi; Yoshinori Misawa; Elisabeth Guinet; Mahyar Nouri-Shirazi; C Kathleen Dorey; Ruth Ann Henriksen; Yoshimi Shibata
Journal:  J Leukoc Biol       Date:  2011-03-29       Impact factor: 4.962

9.  Severe gammaherpesvirus-induced pneumonitis and fibrosis in syngeneic bone marrow transplant mice is related to effects of transforming growth factor-β.

Authors:  Stephanie M Coomes; Sara Farmen; Carol A Wilke; Yasmina Laouar; Bethany B Moore
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

Review 10.  Dual role of arginine metabolism in establishing pathogenesis.

Authors:  Mayuri Gogoi; Akshay Datey; Keith T Wilson; Dipshikha Chakravortty
Journal:  Curr Opin Microbiol       Date:  2015-11-21       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.